Rapp, P.E.; Cellucci, C.; Darmon, D.; Keyser, D. Cautionary Observations Concerning the Introduction of Psychophysiological Biomarkers into Neuropsychiatric Practice. Psychiatry Int.2022, 3, 181-205.
Rapp, P.E.; Cellucci, C.; Darmon, D.; Keyser, D. Cautionary Observations Concerning the Introduction of Psychophysiological Biomarkers into Neuropsychiatric Practice. Psychiatry Int. 2022, 3, 181-205.
Rapp, P.E.; Cellucci, C.; Darmon, D.; Keyser, D. Cautionary Observations Concerning the Introduction of Psychophysiological Biomarkers into Neuropsychiatric Practice. Psychiatry Int.2022, 3, 181-205.
Rapp, P.E.; Cellucci, C.; Darmon, D.; Keyser, D. Cautionary Observations Concerning the Introduction of Psychophysiological Biomarkers into Neuropsychiatric Practice. Psychiatry Int. 2022, 3, 181-205.
Abstract
The combination of statistical learning technologies with large databases of psychophysiological data has appropriately generated enthusiastic interest in future clinical applicability. It is argued here that this enthusiasm should be tempered with the understanding that significant obstacles must be overcome before the systematic introduction of psychophysiological measures into neuropsychiatric practice becomes possible. The nonspecificity of psychophysiological measures complicates their use in diagnosis. Low test-retest reliability complicates use in longitudinal assessment, and quantitative psychophysiological measures can normalize in response to placebo intervention. Ten cautionary observations are introduced and, in some instances, possible directions for remediation are suggested.
Medicine and Pharmacology, Psychiatry and Mental Health
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
